MedDay Pharmaceuticals Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Out of Business

  • Employees
  • 82

Employees

  • Latest Deal Type
  • Out of Business

MedDay Pharmaceuticals General Information

Description

Developer of novel therapeutics intended to focus on the treatment of nervous system disorders. The company's therapeutics offers neuroprotective and neuro repair treatment by investigating brain metabolism to address neurodegenerative diseases, enabling patients to get a recovery from nervous system disorders.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 24-26 Rue de la Pépinière
  • 75008 Paris
  • France
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Vertical(s)
Corporate Office
  • 24-26 Rue de la Pépinière
  • 75008 Paris
  • France

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MedDay Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 25-Mar-2021 Completed Out of Business
2. Early Stage VC (Series B) 08-Apr-2016 Completed Generating Revenue
1. Early Stage VC (Series A) 09-Apr-2013 $10.3M $10.3M Completed Startup
To view MedDay Pharmaceuticals’s complete valuation and funding history, request access »

MedDay Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series B
Series A 6,666,000 $1.35 $1.35 1x $1.35 41.73%
To view MedDay Pharmaceuticals’s complete cap table history, request access »

MedDay Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of novel therapeutics intended to focus on the treatment of nervous system disorders. The company's therapeuti
Biotechnology
Paris, France
82 As of 2020

Bedminster, NJ
 

Kalamazoo, MI
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

MedDay Pharmaceuticals Competitors (77)

One of MedDay Pharmaceuticals’s 77 competitors is Intracellular Therapies, a Formerly VC-backed company based in Bedminster, NJ.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Intracellular Therapies Formerly VC-backed Bedminster, NJ
Metabolic Solutions Development Company Venture Capital-Backed Kalamazoo, MI
ACADIA Pharmaceuticals Formerly VC-backed San Diego, CA
AB Science Formerly Accelerator/Incubator backed Paris, France
Abeona Therapeutics Corporation Cleveland, OH
You’re viewing 5 of 77 competitors. Get the full list »

MedDay Pharmaceuticals Patents

MedDay Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3603649-A1 Method for treating prion diseases Pending 31-Jul-2018
WO-2020025598-A1 Method for treating prion diseases Inactive 31-Jul-2018
EP-3593819-A1 Compositions for therapeutic uses containing 5-htp and carbidopa Inactive 10-Jul-2018
WO-2020011753-A1 Compositions for therapeutic uses containing 5-htp and carbidopa Inactive 10-Jul-2018
AU-2017303346-A1 Method for treating hepatic encephalopathy Inactive 29-Jul-2016 A61K31/4188
To view MedDay Pharmaceuticals’s complete patent history, request access »

MedDay Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MedDay Pharmaceuticals Acquisitions (2)

MedDay Pharmaceuticals’s most recent deal was a Merger/Acquisition with Profilomic. The deal was made on 06-Mar-2017.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Profilomic 06-Mar-2017 Merger/Acquisition Other Pharmaceuticals and Biotechnology
Profilomic (Health Division) 06-Mar-2017 Merger/Acquisition Other Healthcare Services
To view MedDay Pharmaceuticals’s complete acquisitions history, request access »

MedDay Pharmaceuticals FAQs

  • When was MedDay Pharmaceuticals founded?

    MedDay Pharmaceuticals was founded in 2011.

  • Where is MedDay Pharmaceuticals headquartered?

    MedDay Pharmaceuticals is headquartered in Paris, France.

  • What is the size of MedDay Pharmaceuticals?

    MedDay Pharmaceuticals has 82 total employees.

  • What industry is MedDay Pharmaceuticals in?

    MedDay Pharmaceuticals’s primary industry is Biotechnology.

  • Is MedDay Pharmaceuticals a private or public company?

    MedDay Pharmaceuticals is a Private company.

  • What is MedDay Pharmaceuticals’s current revenue?

    The current revenue for MedDay Pharmaceuticals is .

  • How much funding has MedDay Pharmaceuticals raised over time?

    MedDay Pharmaceuticals has raised $48.9M.

  • Who are MedDay Pharmaceuticals’s competitors?

    Intracellular Therapies, Metabolic Solutions Development Company, ACADIA Pharmaceuticals, AB Science, and Abeona Therapeutics are some of the 77 competitors of MedDay Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process